Global Fertility Test Market Trends, Forecast Report 2025-2037
Fertility Test Market size is projected to grow from USD 588.81 million to USD 1.67 billion, demonstrating a CAGR of over 8.3% during the forecast period, between 2025 and 2037. In the year 2025, the industry size of fertility test is evaluated at USD 628.38 million.
The market growth is primarily attributed to growing prevalence of polycystic ovarian syndrome among female population. Between 4% and 20% of people worldwide are believed to have PCOS. According to estimates from the World Health Organization (WHO), PCOS affects about 116 million women worldwide (3.4%).
Besides this, rise in number of people suffering with infertility will boost the fertility test market growth. There are many factors that contribute to infertility, including low sperm count and limited sperm motility in men and failure to ovulate, damaged cervixes and fallopian tubes in women. The World Health Organization (WHO) statistics show that 186 million people worldwide, including 45 million couples, are infertile. Furthermore, integration of technology in fertility test is anticipated to augment the market expansion. For instance, the development of artificial intelligence in IVF could be advantageous to the entire process. According to the National Library of Medicine, AI can recognize human sperm with an accuracy of 89.9% and properly forecast whether a live delivery will occur.
Fertility Test Sector: Growth Drivers and Challenges
Growth Drivers
- Higher Number of Women Suffering with PCOD & Obesity One of the most prevalent but manageable reasons of infertility in women is PCOS. The hormonal imbalance in PCOS patients prevents the development and release of eggs from the ovaries
- PCOS is one of the most common causes of female infertility, affecting 6% to 12% totaled to 5 million women of reproductive age in the United States.
- Rising Infertility Cases - According to the National Library of Medicine, 15% of couples worldwide struggle with infertility. Around 20–30% of cases of infertility are caused by males, who also contribute 50% overall.
- Increase in the Mean Age of First Motherhood- By the end of 2019, the average age of women experiencing their first pregnancy grew from 29 to 30 internationally, according to figures from the OECD Family Database. The only OECD nation with a mean average age of 28 or less is Mexico.
- Higher Consumption of Alcohol, and Tobacco Consumption- Adult drug, alcohol, and tobacco use has increased, which is attributed to busy lifestyles and environmental changes. More than one-third of all male adults globally use tobacco, and over 30% of women of reproductive age smoke, according to BioMed Central Ltd. Smoking has, on average, raised the chance of infertility by 60%. Owing to the alteration in their hormonal levels, both men and women who take substances like marijuana, cocaine, and performance-enhancing drugs likely to have problems getting pregnant.
- Better Funding and Insurance Coverage has Increased- The frequency of IVF operations has increased as a result of government assistance in the form of money and insurance coverage across several nations worldwide. Singapore has the most expensive IVF procedures, with expenses ranging from USD 10,000 to USD 15,000 USD per cycle, however the Medicare System covers roughly 95% of the cost, according to a National Library of Medicine report.
Challenges
- Social Stigma Associated with Fertility Tests in Several Countries
- Lack of Awareness about Fertility Test in Rural Areas - The lack of accuracy in urine-based monitoring of ovulation, can lead to faulty track of fertile window, and if a couple is trying to conceive, they might miss a crucial period of ovulation. The accuracy can occur due to surge of luteinizing hormone in women who is taking the test, which gives false alarm. Therefore, inaccuracy can affect the growth of fertility test market.
- Unproven Accuracy of Urine-Based Ovulation Monitoring
Fertility Test Market: Key Insights
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
8.3% |
|
Base Year Market Size (2024) |
USD 588.81 million |
|
Forecast Year Market Size (2037) |
USD 1.67 billion |
|
Regional Scope |
|
Fertility Test Segmentation
End-user (Home Care, Fertility Clinics, Hospitals)
The home care segment is expected to dominate largest market share by 2037, on the account of higher number of people using fertility test at home and there have been significant rise in male home-fertility testing as the rate of infertility is constantly increasing. Around 40%-50% of fertility problems in couple is attributed to male fertility.
Our in-depth analysis of the global market includes the following segments:
|
By Product |
|
|
By Mode of Purchase |
|
|
By End User |
|
Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.
Customize this ReportFertility Test Industry - Regional Synopsis
The North America fertility test market is predicted to hold majority revenue share by the end of 2037, on the back of rise in the cases of infertility. In the United States, 1 in 5 heterosexual women between the ages of 15 and 49 who have never given birth are unsuccessful in getting pregnant after a year of trying (infertility). Additionally, 26% of the women in this group report having trouble getting pregnant or bringing a pregnancy to term. Furthermore, the rise in the average age of women conceiving for the first time is to propel the rate infertility. Birthrates for women in their 20s have decreased, while those for women in their late 30s and early 40s have increased in the U.S. The median age of U.S. women giving birth has increased from 27 to 30, the highest age ever.
Companies Dominating the Fertility Test Landscape
- Swiss Precision Diagnostics
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Legacy, Inc.
- Dadi Inc.
- Everlywell, Inc.
- Fertility Focus
- ExSeed Health
- Geratherm Medical
- VirtualExpo
- AdvaCare Pharma
- Valley Electronics AG
In the News
-
Kindbody launched the Kind at Home fertility test for both men and women. It can be easily used at home; it also provides detailed information about the fertility status along with customizes recommendation by doctors.
-
Fertility Focus launched the OvyFirst, it is sensor device which estimates the body temperature and predict best time for the women to conceive
Author Credits: Radhika Pawar
- Report ID: 3231
- Published Date: Jan 28, 2025
- Report Format: PDF, PPT
